The Paradigm Evolves

November 13 – 14, 2019 • Harvard Medical School, Boston, MA

The 15th Annual Personalized Medicine Conference at Harvard Medical School will explore the science, business, and policy issues facing personalized medicine as scientists refine their understanding of how groundbreaking molecular diagnostics augmented by artificial intelligence, advanced data analytics, and digital health applications can empower both physicians and patients with information about how an expanded set of biological characteristics — including those found in the proteome and microbiome — may influence their health and their responses to increasingly impactful therapies.

  • [As] physiologic data points are integrated with other parameters such as genomics and metabolomics … [personalized medicine] may move from a reactive state to a proactive state.

    William S. Dalton, Ph.D., M.D., Founder, Executive Chairman, M2Gen
  • With new biomarkers coming on line, we probably will be able to diagnose much better who will respond best to therapy. That means we have to develop drugs and diagnostics together.

    Paul Stoffels, M.D., Vice Chairman, Executive Committee, Chief Scientific Officer, Johnson & Johnson
  • Momentum toward a universal digital future in health care is advancing. Due to the great promise of these technologies ... FDA is working to modernize our regulatory approach to better enable and more efficiently spur innovation.

    Jeffrey E. Shuren, M.D., J.D., Director, Center for Devices and Radiological Health, U.S. Food and Drug Administration

Conference

Learn about the venue, organizers and history of the conference.

LEARN MORE

Schedule

View the conference program.

Schedule

Confirmed Speakers

View a list of confirmed speakers.

Speakers

Confirmed Speakers

Bonnie J. Addario

Co-Founder, Chair

GO2 Foundation for Lung Cancer

Sarah K. Emond, M.P.P.

Executive Vice President, Chief Operating Officer

Institute for Clinical and Economic Review

Kris Joshi, Ph.D.

Executive Vice President; President, Network Solutions

Change Healthcare

Peter Maag, Ph.D.

CEO, President

CareDx

Lincoln Nadauld, M.D., Ph.D.

Chief, Precision Health

Intermountain Healthcare

Kenna R. Mills Shaw, Ph.D.

Executive Director

MD Anderson Institute for Personalized Cancer Therapy

Michael Sherman, M.D., M.B.A., M.S.

Chief Medical Officer, Senior Vice President

Harvard Pilgrim Health Care

Roy Smythe, M.D.

CEO

SomaLogic

Paul Stoffels, M.D.

Vice Chairman, Executive Committee; Chief Scientific Officer

Johnson & Johnson

View full List of Speakers

Sponsors

View full List of Sponsors